Healthcare entity
All 1 tracked stories fall under one category: health-it. Longeveron Inc. is most often covered alongside Kaltura, Inc., which appears in 1 of these 1 story. Source depth averages 4 original sources per story, versus 3 across the same-window beat baseline.
Last mentioned: Mar 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: health-it. Longeveron Inc. is most often covered alongside Kaltura, Inc., which appears in 1 of these 1 story. Source depth averages 4 original sources per story, versus 3 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.9 in the same window. Longeveron Inc. appears in 1 tracked Healthcare story from March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Longeveron Inc.. Shared-story counts are live from our verified record — not editorial picks.
Kaltura reports Q4 2025 results as it deepens its footprint in healthcare video solutions, while Longeveron faces listing challenges despite clinical progress with its Lomecel-B therapy. The dual reports underscore the diverging paths of established Health IT infrastructure versus high-risk clinical stage biotechnology.
Source: insidermonkey.com · insidermonkey.com
Longeveron Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
